Overview

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The study will compare the safety and efficacy of a generic mometasone nasal spray to the reference listed drugs in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations will be tested for superiority against a placebo nasal spray.

Phase:

Phase 1

Details

Lead Sponsor:

Mylan Pharmaceuticals

Treatments:

Mometasone Furoate